The trademark DEPODEX was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on September 30, 2001, and received one opposition filed on December 12, 2001 by STADA Arzneimittel AG on Likelihood of confusion. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 12, 2001
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
The renewal of the trademark was recorded by the office on August 20, 2011.
of the trademark registration was recorded on August 20, 2011. Change of name and address of the trademark registration was recorded on October 24, 2009. Change of name and professional address of the trademark registration was recorded on June 28, 2010.
The Opposition with reference B 000465098 was rejected according to Article 8(1)(b) CTMR with decision issued on November 27, 2003 by the EUIPO.